Underdog Pharmaceuticals Funding & Investors
Plano, TX
Underdog Pharmaceuticals is pursuing a mission to treat the underlying causes of age-related disease. The company develops simple and direct interventions targeting toxic forms of cholesterol, using rationally designed molecules, to provide the first true disease-modifying treatments for age-related diseases such as atherosclerosis, hypercholesterolemia, heart failure, and macular degeneration. Its products are based on novel derivatives of a well-known, safe compound, and a new way of looking at cardiovascular disease created through a SENS Research Foundation program.
underdogpharma.comTotal Amount Raised: $115,000,000
Underdog Pharmaceuticals' Investors
Underdog Pharmaceuticals Funding Rounds
Series C
$70,000,000
Series C Investors
Spark CapitalSeries B
$35,000,000
Series B Investors
BlackrockAcies InvestmentsElectric Feel VenturesSeries A
$10,000,000
Series A Investors
Kevin CarterLionTree Advisors FranceKevin DurantSV AngelBreon CorcoranMark CubanSteve AokiRoham GharegozlouMark PincusPalm Tree Crew HoldingsAustin Rief VenturesEilers & Krejcik GamingThe ChainsmokersThirty Five VenturesMantis.Matthew DellavedovaWilliam ChandlerHBSE VenturesJared GoffNitesh BantaAAFMTrae YoungOdell Beckham Jr.Mitch GarberDJ KygoNasNayvadius Dumun Wilburn
Funding info provided by Diffbot.